CDKN2A and diabetes mellitus: Taken together, these observations suggest that disruption of Cdk4 activity, regulation of its downstream effectors like E2F3, or aberrant activation of its inhibitor p16Ink4a could simultaneously disable glucose-stimulated insulin secretion and insulin action — two prominent facilitators of diabetes progression.